Table of Contents

2019-2024 Global Rilpivirine Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Rilpivirine Consumption 2014-2024
  • 2.1.2 Rilpivirine Consumption CAGR by Region
• 2.2 Rilpivirine Segment by Type
  • 2.2.1 Self-production API
  • 2.2.2 Outsourcing of API
• 2.3 Rilpivirine Consumption by Type
  • 2.3.1 Global Rilpivirine Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Rilpivirine Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Rilpivirine Sale Price by Type (2014-2019)
• 2.4 Rilpivirine Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Clinic
  • 2.4.3 Drug Center
  • 2.4.4 Other
• 2.5 Rilpivirine Consumption by Application
  • 2.5.1 Global Rilpivirine Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Rilpivirine Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Rilpivirine Sale Price by Application (2014-2019)

3 Global Rilpivirine by Manufacturers

• 3.1 Global Rilpivirine Sales Market Share by Manufacturers
  • 3.1.1 Global Rilpivirine Sales by Manufacturers (2017-2019)
  • 3.1.2 Global Rilpivirine Sales Market Share by Manufacturers (2017-2019)
• 3.2 Global Rilpivirine Revenue Market Share by Manufacturers
  • 3.2.1 Global Rilpivirine Revenue by Manufacturers (2017-2019)
  • 3.2.2 Global Rilpivirine Revenue Market Share by Manufacturers (2017-2019)
• 3.3 Global Rilpivirine Sale Price by Manufacturers
• 3.4 Global Rilpivirine Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
  • 3.4.1 Global Rilpivirine Manufacturing Base Distribution and Sales Area by Manufacturers
  • 3.4.2 Players Rilpivirine Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Rilpivirine by Regions

• 4.1 Rilpivirine by Regions
  • 4.1.1 Global Rilpivirine Consumption by Regions
  • 4.1.2 Global Rilpivirine Value by Regions
• 4.2 Americas Rilpivirine Consumption Growth
• 4.3 APAC Rilpivirine Consumption Growth
• 4.4 Europe Rilpivirine Consumption Growth
• 4.5 Middle East & Africa Rilpivirine Consumption Growth

5 Americas

• 5.1 Americas Rilpivirine Consumption by Countries
  • 5.1.1 Americas Rilpivirine Consumption by Countries (2014-2019)
  • 5.1.2 Americas Rilpivirine Value by Countries (2014-2019)
• 5.2 Americas Rilpivirine Consumption by Type
• 5.3 Americas Rilpivirine Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Rilpivirine Consumption by Countries
  • 6.1.1 APAC Rilpivirine Consumption by Countries (2014-2019)
  • 6.1.2 APAC Rilpivirine Value by Countries (2014-2019)
• 6.2 APAC Rilpivirine Consumption by Type
• 6.3 APAC Rilpivirine Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Rilpivirine by Countries
  • 7.1.1 Europe Rilpivirine Consumption by Countries (2014-2019)
  • 7.1.2 Europe Rilpivirine Value by Countries (2014-2019)
• 7.2 Europe Rilpivirine Consumption by Type
• 7.3 Europe Rilpivirine Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Rilpivirine by Countries
  • 8.1.1 Middle East & Africa Rilpivirine Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Rilpivirine Value by Countries (2014-2019)
• 8.2 Middle East & Africa Rilpivirine Consumption by Type
• 8.3 Middle East & Africa Rilpivirine Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Rilpivirine Distributors
• 10.3 Rilpivirine Customer

11 Global Rilpivirine Market Forecast

• 11.1 Global Rilpivirine Consumption Forecast (2019-2024)
• 11.2 Global Rilpivirine Forecast by Regions
  • 11.2.1 Global Rilpivirine Forecast by Regions (2019-2024)
  • 11.2.2 Global Rilpivirine Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Rilpivirine Forecast by Type
• 11.8 Global Rilpivirine Forecast by Application

12 Key Players Analysis

• 12.1 Janssen Cilag International
  • 12.1.1 Company Details
  • 12.1.2 Rilpivirine Product Offered
  • 12.1.3 Janssen Cilag International Rilpivirine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Janssen Cilag International News
• 12.2 Gilead Sciences
  • 12.2.1 Company Details
  • 12.2.2 Rilpivirine Product Offered
  • 12.2.3 Gilead Sciences Rilpivirine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Gilead Sciences News
• 12.3 ViiV Healthcare
  • 12.3.1 Company Details
  • 12.3.2 Rilpivirine Product Offered
  • 12.3.3 ViiV Healthcare Rilpivirine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 ViiV Healthcare News
• 12.4 Strides Pharma Science Limited
  • 12.4.1 Company Details
  • 12.4.2 Rilpivirine Product Offered
  • 12.4.3 Strides Pharma Science Limited Rilpivirine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Strides Pharma Science Limited News
• 12.5 Pharmacare Limited
  • 12.5.1 Company Details
  • 12.5.2 Rilpivirine Product Offered
  • 12.5.3 Pharmacare Limited Rilpivirine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Pharmacare Limited News
• 12.6 Aspen
  • 12.6.1 Company Details
  • 12.6.2 Rilpivirine Product Offered
  • 12.6.3 Aspen Rilpivirine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Aspen News

...

13 Research Findings and Conclusion

According to this study, over the next five years the Rilpivirine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Rilpivirine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Rilpivirine market by product type, application, key manufacturers and key regions and countries.

This study considers the Rilpivirine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Self-production API
Outsourcing of API
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Drug Center
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Janssen Cilag International
Gilead Sciences 
ViiV Healthcare
Strides Pharma Science Limited
Pharmacare Limited
Aspen
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Rilpivirine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Rilpivirine market by identifying its various subsegments.
Focuses on the key global Rilpivirine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Rilpivirine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Rilpivirine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.